CIK 0001701108
- Non-accelerated filer
- Smaller reporting company
Spero Therapeutics, Inc.
Sign in to watch- Ticker
- SPRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-242-1600
- Business address
- 675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE, MA, 02139
- Former names
- Spero Therapeutics, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $42,485
- in 1 filing
Net −$42,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-08 | Aquilo Capital Management, LLC 10% owner | Sale | −3,000 | $21.74 | $65K | 3,829,209 |
| 2021-02-04 | Aquilo Capital Management, LLC 10% owner | Sale | −34,144 | $18.99 | $648K | 3,832,209 |
| 2021-02-03 | Aquilo Capital Management, LLC 10% owner | Sale | −29,354 | $18.98 | $557K | 3,866,353 |
| 2021-02-02 | Aquilo Capital Management, LLC 10% owner | Sale | −22,841 | $18.99 | $434K | 3,895,707 |
| 2021-02-01 | Aquilo Capital Management, LLC 10% owner | Sale | −13,661 | $19.24 | $263K | 3,918,548 |
| 2021-02-01 | Keutzer Timothy Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +57,432 | 57,432 | ||
| 2021-02-01 | Larkin Cristina Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +57,432 | 57,432 | ||
| 2021-02-01 | Mahadevia Ankit | Grant or award · Stock Option (Right to Buy) | +179,319 | 179,319 | ||
| 2021-02-01 | Melnick David A. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +57,432 | 57,432 | ||
| 2021-01-04 | VINK PATRICK V.J.J. Director | Grant or award · Stock Option (right to buy) | +1,314 | $13.31 | $17K | 1,314 |
| 2021-01-04 | Smith Cynthia Director | Grant or award · Stock Option (right to buy) | +2,629 | $13.31 | $35K | 2,629 |
| 2021-01-04 | THOMAS FRANK E Director | Grant or award · Stock Option (right to buy) | +1,314 | $13.31 | $17K | 1,314 |
| 2021-01-04 | Deshpande Milind Director | Grant or award · Stock Option (right to buy) | +2,629 | $13.31 | $35K | 2,629 |
| 2021-01-04 | Shukla Sath Chief Financial Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2020-12-17 | Aquilo Capital Management, LLC 10% owner | Sale | −250,000 | $18.81 | $4.7M | 3,932,209 |
| 2020-12-16 | Aquilo Capital Management, LLC 10% owner | Sale | −14,933 | $18.62 | $278K | 4,182,209 |
| 2020-12-16 | Larkin Cristina Chief Operating Officer | Exercise or conversion | +12,000 | $5.90 | $71K | 13,500 |
| 2020-12-16 | Larkin Cristina Chief Operating Officer | Sale | −12,000 | $19.00 | $228K | 1,500 |
| 2020-12-16 | Larkin Cristina Chief Operating Officer | Exercise or conversion · Stock Option (Right to Buy) | −12,000 | 8,434 | ||
| 2020-12-02 | JOSEPH TAMARA L Chief Legal Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 |
Page 10 of 17 · 340 trades